Lin Yu

1.5k total citations
68 papers, 952 citations indexed

About

Lin Yu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Lin Yu has authored 68 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 19 papers in Rheumatology. Recurrent topics in Lin Yu's work include Sarcoma Diagnosis and Treatment (25 papers), Soft tissue tumor case studies (15 papers) and Vascular Tumors and Angiosarcomas (10 papers). Lin Yu is often cited by papers focused on Sarcoma Diagnosis and Treatment (25 papers), Soft tissue tumor case studies (15 papers) and Vascular Tumors and Angiosarcomas (10 papers). Lin Yu collaborates with scholars based in China, United States and Singapore. Lin Yu's co-authors include I Weng Lao, Jian Wang, Jian Wang, Lei Wang, Wentao Yang, Meng Sun, Xiaohang Liu, Jian Wang, Ruoji Zhou and Xiu Qin Xu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Lin Yu

65 papers receiving 937 citations

Peers

Lin Yu
Comparison fields: 5 of 97
  • Pulmonary and Respiratory Medicine 383
  • Oncology 253
  • Rheumatology 210
  • Molecular Biology 189
  • Surgery 154
Replace Angela Tamburini with:
Angela Tamburini Italy
Judy A. Tjoe United States
Jennifer L. Halpern United States
Susanne Oertel Germany
D. Carrle Germany
Nong Lin China
Reynaldo Jesús-García Brazil
Jacob Engellau Sweden
Giacomo Miserocchi Italy
Odd R. Monge Norway
Angela Tamburini Italy View profile →
Citations per field, relative to Lin Yu
Lin Yu · 1×
Citations per year, relative to Lin Yu
Lin Yu · 1×

Countries citing papers authored by Lin Yu

Since Specialization
Citations

This map shows the geographic impact of Lin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Yu more than expected).

Fields of papers citing papers by Lin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Yu. The network helps show where Lin Yu may publish in the future.

Co-authorship network of co-authors of Lin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Yu. A scholar is included among the top collaborators of Lin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Yu. Lin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 3
3 28
4 2
5 10
6 3
7 20
8 5
9 11
10 13
11 21
12 19
13 17
14 18
15 21
16 5
17 8
18 4
19 26
20
Toxic reactions after late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for esophageal carcinoma
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026